| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,404 | $8.92 | 50,005 | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 13,453 | -- | -- | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,610 | -- | 56,119 | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4/A | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,103 | $8.92 | 53,016 | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 13,453 | -- | -- | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,588 | -- | 58,716 | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,176 | -- | 21,176 | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,913 | -- | 21,913 | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,415 | -- | 61,543 | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,230 | $8.92 | 60,313 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.